Global Stem Cells Group Takes Part in Clinical Trial.

Global Stem Cells Group, a multi-disciplinary community of scientists and physicians collaborating to

treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced their

participation in a clinical trial designed to explore the safety and improvement of treatment protocols using adipose-derived

stem cells.

The purpose of the investigation is to evaluate the safety of and superior effectiveness of adipose-derived stem cells in functional improvement in patients with partial-thickness rotator cuff tears (PTRCTs). The study will examine treatment results after the administration of a single injection of adipose-derived regenerative cells (ADRCs) into the partial-thickness rotator cuff tear compared to the administration of a single corticosteroid injection into the associated subacromial space.

Up to 20 centers in the United States have will be invited to enroll in the study. The trial seeks to target 246 subjects, with arandomized selection of which injection each subject will receive: the adipose-derived regenerative cell (ADRC) injection (ADRC treatment arm) or the SOC corticosteroid injection (active control arm). All subjects will be randomly assigned to the ADRC treatment or active control treatment at a 2:1 ratio.

The study is a double-blind trial in which the subject, post-procedural investigator and imaging core laboratorial radiologists are blinded. For more details on this clinical study, visit https://bit.ly/2Jw04aX.

Faculty members from the Global Stem Cells Group will be treating subjects enrolled in the study. Global was chosen to participate in this study due to its unique stature as a leader in regenerative medicine. The group is known for its comprehensive support of regenerative medicine solutions, starting with education, patient treatment and research and ending with the manufacturing and distribution of equipment for regenerative medicine practitioners.

To learn more about the Global Stem Cells Group, visit https://www.stemcellsgroup.com/.